Top Midday Gainers

MT Newswires Live
Aug 06, 2024

Top Midday Gainers

TenX Keane Acquisition (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius Oncology Inc.

TenX shares skyrocketed 192% as intraday trading volume surged to over 1.3 million from a daily average of about 11,000.

Zevra Therapeutics (ZVRA) shares soared after the company said Friday that a US Food and Drug Administration advisory committee voted in favor of the data supporting arimoclomol as a treatment for patients with Niemann-Pick disease Type C, an inability of the body to transport cholesterol and other lipids within the cell.

Shares advanced 29% as intraday trading volume rose to over 7.4 million versus the stock's daily average of about 406,000.

Thoughtworks (TWKS) said Monday it entered into a definitive merger agreement in which an affiliate of funds advised by Apax Partners will buy all outstanding Thoughtworks common stock that they do not already own for $4.40 per share.

Shares rose 26% as intraday trading volume catapulted to more than 35.6 million from a daily average of about 797,000.

Price: 32.95, Change: +20.64, Percent Change: +167.67

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10